An integrated molecular approach for the detection and species-level identification of <i>Leishmania</i> spp. in clinical samples. [PDF]
Risso MG +11 more
europepmc +1 more source
Iceberg phenomenon in cutaneous leishmaniasis: A sporotrichoid clue. [PDF]
Okan G, Ozates M.
europepmc +1 more source
Evidence Gaps and Global Patterns in Leishmaniasis Control: A Scoping Review of Clinical, Diagnostic, and Treatment Strategies. [PDF]
Mohammed MW +4 more
europepmc +1 more source
Cutaneous Leishmaniasis in Patients under Biologic Therapies: A Spanish CLINI-AEDV Multicentre Study. [PDF]
Ciudad A +27 more
europepmc +1 more source
Therapeutic challenges in relapsing cutaneous and visceral leishmaniasis caused by Leishmania (Mundinia) martiniquensis in patients with advanced HIV disease from Southern Thailand. [PDF]
Phadungsaksawasdi K +11 more
europepmc +1 more source
Fifteen-Year Evolution of Chronic Cutaneous Leishmaniasis Mimicking Other Dermatoses. [PDF]
Hurtado-Rossi L +3 more
europepmc +1 more source
Cutaneous and Mucocutaneous Leishmaniasis
Leishmaniasis is a chronic disease caused by flagellate protozoa of the genus Leishmania. It is a global disease, but most cases are seen in South America, the Mediterranean, and some areas of Asia and Africa. The 3 main types of leishmaniasis are cutaneous (the most common), mucocutaneous, and visceral (the most severe). Visceral leishmaniasis is also
Isabel Abadías-Granado +2 more
exaly +7 more sources
Related searches:
Cutaneous and Mucocutaneous Leishmaniasis
Infectious Disease Clinics of North America, 2012Tegumentary leishmaniases are caused by approximately 15 species of protozoa of the genus Leishmania. They prevail in tropical and subtropical areas of the Old and New World but human mobility also makes them a medical problem in nonendemic areas. Clinical manifestations may comprise cutaneous and mucocutaneous forms that may be localized, disseminated,
Hiro Gotō, Lindoso Jal
exaly +3 more sources

